GGrantIndex
← Leaderboards

Nathan Oliver Stitziel

Washington University

$30,076,422
Attributed
$70,577,874
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $17.1M · FY201225
$20M$15M$10M$5M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$70,577,874 · 8

By mechanism

UM1$59,673,846 · 1
R01$6,854,318 · 3
P01$3,346,459 · 3
K08$703,251 · 1

Top collaborators

Most similar at Washington University

Same institution · by research overlap

Others in their field

Top investigators on “Variant

Research focus

VariantPathway InteractionsHuman GeneticsPhenotypeAllelesCardiovascular DiseasesResearch PersonnelGeneticLeadNovel StrategiesLipidsLdl Cholesterol LipoproteinsAtherosclerosisProteinsGenesBiologyProgramsRisk FactorsInsightSuccessCoronary ArteriosclerosisGenetic AssociationGenomeFamily

Grant awards (28)

A paradigm for comprehensive genetic association studies of complex disease using pangenomic methods and local ancestry inference$711,447
R01 · FY2025 · HG
Project 2: ANGPTL3-dependent mechanisms underlying adaptations in hepatic lipoprotein production and clearance$633,102
P01 · FY2025 · HL · contact PI
Mechanistic Studies of the Novel Human Coronary Artery Disease Gene SVEP1$530,735
R01 · FY2025 · HL · contact PI
BIOINFORMATICS CORE$337,604
P01 · FY2025 · HL · contact PI
A paradigm for comprehensive genetic association studies of complex disease using pangenomic methods and local ancestry inference$726,330
R01 · FY2024 · HG
Mechanistic Studies of the Novel Human Coronary Artery Disease Gene SVEP1$527,741
R01 · FY2024 · HL · contact PI
Project 2: Regulation of lipid and glucose metabolism by ANGPTL3 in humans$466,793
P01 · FY2024 · HL · contact PI
Mechanistic Studies of the Novel Human Coronary Artery Disease Gene SVEP1$548,627
R01 · FY2023 · HL · contact PI
Project 2: Regulation of lipid and glucose metabolism by ANGPTL3 in humans$476,409
P01 · FY2023 · HL · contact PI
Mechanistic Studies of the Novel Human Coronary Artery Disease Gene SVEP1$565,912
R01 · FY2022 · HL · contact PI
Project 2: Regulation of lipid and glucose metabolism by ANGPTL3 in humans$474,337
P01 · FY2022 · HL · contact PI
Project 2: Regulation of lipid and glucose metabolism by ANGPTL3 in humans$474,343
P01 · FY2021 · HL · contact PI
A Platform for Large-Scale Discovery in Common Disease$13,031,931
UM1 · FY2020 · HG · contact PI
ANGPTL3 DEFICIENCY AND ATHEROSCLEROSIS IN HUMANS$546,270
R01 · FY2020 · HL · contact PI
Project 2: Regulation of lipid and glucose metabolism by ANGPTL3 in humans$483,871
P01 · FY2020 · HL · contact PI
A Platform for Large-Scale Discovery in Common Disease$15,000,000
UM1 · FY2019 · HG · contact PI
ANGPTL3 DEFICIENCY AND ATHEROSCLEROSIS IN HUMANS$669,213
R01 · FY2019 · HL · contact PI
A Platform for Large-Scale Discovery in Common Disease$15,000,000
UM1 · FY2018 · HG
ANGPTL3 DEFICIENCY AND ATHEROSCLEROSIS IN HUMANS$669,213
R01 · FY2018 · HL · contact PI
Genome Aggregation and Joint Variant Calling for CCDG Freeze2$249,951
UM1 · FY2018 · HG
A Platform for Large-Scale Discovery in Common Disease$16,391,964
UM1 · FY2017 · HG
ANGPTL3 DEFICIENCY AND ATHEROSCLEROSIS IN HUMANS$663,467
R01 · FY2017 · HL · contact PI
ANGPTL3 DEFICIENCY AND ATHEROSCLEROSIS IN HUMANS$695,363
R01 · FY2016 · HL · contact PI
Rare coding variation and risk for myocardial infarction$154,611
K08 · FY2016 · HL · contact PI
Rare coding variation and risk for myocardial infarction$137,160
K08 · FY2015 · HL · contact PI
Rare coding variation and risk for myocardial infarction$137,160
K08 · FY2014 · HL · contact PI
Rare coding variation and risk for myocardial infarction$137,160
K08 · FY2013 · HL · contact PI
Rare coding variation and risk for myocardial infarction$137,160
K08 · FY2012 · HL · contact PI